Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Henggu Pharmaceutical is a specialized pharmaceutical company based in Kunming, China, primarily focused on the development and production of Traditional Chinese Medicine (TCM) for orthopedic applications. The company's core product, Henggu Gushang Ji, is a proprietary liquid formulation widely used to treat conditions such as bone fractures, osteoarthritis, and osteonecrosis of the femoral head. Yunnan Henggu operates modern, GMP-certified manufacturing facilities and has established a significant clinical reputation within the Chinese healthcare system for musculoskeletal recovery. Their research efforts focus on integrating traditional herbal wisdom with modern pharmacological standards to promote bone healing and reduce inflammation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Henggu Pharmaceutical.